Abstract:Humans have for a long time contemplated the link between diet and disease. As early as 400 BC, Hippocrates, commonly referred to as the father of western medicine, stated, “let food be thy medicine and let medicine be thy food”. Today, a poor diet is still considered one of the major risk factors for common complex diseases such as cardiovascular disease (CVD). CVD refers to a class of diseases that involves heart and blood vessels. According to WHO, CVD is one of the leading causes of morbidity and mortality in the industrialized world [8]. The cause of CVD is multifactorial, of which dyslipidemia plays a central role. Dyslipidemia is a state of elevated low density lipoprotein cholesterol (LDL-C), triglycerides, and/or reduced high density lipoprotein cholesterol (HDL-C). In the past, the treatment strategy of dyslipidemia has involved pharmacological intervention (e.g. statins or fibrates) to lower serum LDL-C and triglycerides. However, it is not until recently that the importance of diet and lifestyle are emphasized in clinical treatment and prevention of dyslipidemia. The classic ‘diet-heart’ hypothesis postulates that high intake of foods rich in fat raise the level of circulating cholesterol and triglycerides in the blood, thereby contributing to the risk of heart disease. However, recent research efforts have shown this hypothesis to be overly simplistic, where total fat intake as percentage of total energy intake is not as important as initially believed, whereas fat quality seems to be much more important. Studies have shown that replacement of saturated fat with mono- or poly- unsaturated fat appears to be beneficial for health whereas there seems to be no clear beneficial effect if saturated fat is replaced with (refined) carbohydrates. Like many other complex diseases, dyslipidemia and CVD are products of a genetic predisposition and environmental risk factors. Large-scale population genetics studies have identified 164 common genetic variants (single nucleotide polymorphisms [SNPs]) associated with lipid levels. It is plausible that environmental factors, including diet, physical activity, alcohol consumption and smoking, may interact with genetic variants to modify circulating lipid levels in the context of dyslipidemia. Studying gene-environment interactions may help explore novel mechanisms of disease, and inform future personalized nutrition/medicine based on genetic make-up. A new research field combining genetics, nutrition and biochemistry emerged in 2000, known as nutrigenetics, to study inter-individual variation in response to diet. If dyslipidemia can be effectively intervened upon through lifestyle, a large proportion of CVD cases could be delayed or even avoided. Furthermore, targeted diet and lifestyle interventions can protect against drug overconsumption, abuse or adverse side effects. Last but not least, compared to the massive costs related to disease diagnosis and treatment, the use of lifestyle interventions to control and prevent disease may prove to be a much more economical and effective way to improve public health interventions targeting populations susceptible to CVD and related traits. The Nunavik Inuit Health Survey comprises a small cohort of adult Inuits (N=553), in which interactions between 35 SNPs (in 20 genes) and components of dietary fat intake on plasma lipid levels were investigated]. 14 interactions with total fat intake, and 13 interactions with saturated fat intake were observed on blood lipid traits (total cholesterol, LDL-C, HDL-C and triglycerides), with an additive effect observed when looking at the combined genetic burden. It is meaningful to replicate the same analysis within a population of European ancestry to verify the reliability of the findings by Rudkowska et al., thus furthering our understanding on the biological mechanism of dyslipidemia.

Network Analysis Identifies NR4A2 with Gene‐Environment Interactions Influencing Inflammation Biomarkers Modified by Fatty Acid Intake in Two Populations

Can Dietary Fat Intake Modify Genetic Associations with Blood Lipid Level? Observations from a Swedish Cohort Study

Immune Cells and Blood Lipids Mediation: a Mendelian Randomization Study on Metabolic Dysfunction-Associated Fatty Liver Disease

Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study

Interaction between Erythrocyte Phospholipid Fatty Acids Composition and Variants of Inflammation-Related Genes on Type 2 Diabetes.

Associations between neighborhood socioeconomic deprivation, IFNγ, and high-density lipoprotein particle size: Data from the Washington, D.C. cardiovascular health and needs assessment

NR4A1 is associated with chronic low-grade inflammation in patients with type 2 diabetes.

Genome-wide association study reveals shared and distinct genetic architecture underlying fatty acid and bioactive oxylipin metabolites in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Abstract 10863: Genome-Wide Assessments of 138 Inflammatory Markers Identified Inflammatory Pathways Confer Cardiovascular Disease Risk

Interleukin-6 Receptor Pathways in Coronary Heart Disease: a Collaborative Meta-Analysis of 82 Studies.

Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study

A proinflammatory diet is associated with inflammatory gene expression among healthy, non-obese adults: Can social ties protect against the risks?

Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis

Increased nuclear receptor subfamily 2, group E, member 1 (NR2E1) concentrations of PBMCs are associated with chronic inflammation in overweight/obesity

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Association between circulating biomarkers and non-alcoholic fatty liver disease: An integrative Mendelian randomization study of European ancestry

Weighted Gene Co-Expression Network Analysis Identifies Gender Specific Modules and Hub Genes Related to Metabolism and Inflammation in Response to an Acute Lipid Challenge

Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses

Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study

Tissue-Specific Differential Expression of Novel Genes and Long Intergenic Noncoding RNAs in Humans with Extreme Response to Evoked Endotoxemia.

P5505Inflammation Implicated in the Aetiology of Major Vascular and Non-Vascular Diseases in East Asians